3D TECHNOLOGY APPLIED TO SURGERY

OBJECTIVE

Position France as world leader in a range of 3D technologies applied to surgery, through the development of 3D modelling of patients, secured patient data transfer systems, new 3D visualisation displays, touchless interface and augmented reality software and glasses.

PARTNERSHIP

The 3D-Surg consortium includes 3 Start-up companies (Visible Patient, Therapixel and Optinvent), 2 SME (Alioscopy and e-Media),
1 group (Altran) and two private institutes (IRCAD and IHU Strasbourg). Associated partners are Alsace Biovalley, Ecole Centrale de Nantes and Satt-Connectus representing 3 research teams of the Strasbourg University i-Cube lab.

Investir l'avenir

PARTNERS

Visible patient

VISIBLE PATIENT

Groupe e-media

GROUPE E-MEDIA

Therapixel

THERAPIXEL

Institute of Image-Guided Surgery

INSTITUTE OF IMAGE-GUIDED SURGERY

IRCAD France

IRCAD FRANCE

Alioscopy

ALIOSCOPY

Optinvent

OPTINVENT

Altran

ALTRAN

ASSOCIATED PARTNERS

Biovalley France

FRANCE BIOVALLEY

EC Nantes

ECOLE CENTRALE DE NANTES

Conectus

SATT-CONNECTUS

Université de Strasbourg

UNIVERSITY OF STRASBOURG

Icube

ICUBE

5 STEPS FOR THE 3D-SURG

MARKET AND FINANCIAL ASPECT

2 billion € in 2016, with an annual 12,7% growth. 3D-Surg project aims to develop more than 12 different products in the next five years.

0billion €

in 2016

with an annual growth

0%
For more information
contact us!

and

0

different products
in the next five years

3D-Surg represents a total investment of 18M€
including 8M€ of BPI support from 2015 to 2019.

Programme Investissement d'Avenir

3D-Surg is a project of the “Programme Investissements d’Avenir – PIA” of the French Government
and benefits from the financial support of the BPI France.